Skip to main content
. 2022 Jan 10;5(4):e202101200. doi: 10.26508/lsa.202101200

Figure S1. Intra-patient time-course variation in ALT, per dose-cohort.

Figure S1.

Shadowed area represents treatment with plitidepsin on days 1 to 3. Each color line represents one patient. Bold line represents median values. ALT, alanine aminotransferase; ULN, upper limit of normal.